جست‌وجوی استاد و پژوهشگر

Eduardo N. Chiniمشاهده پروفایل

استاد

• Metabolism
• NAD Metabolism
• Aging
• +۱۱ مورد دیگر

Eduardo N. Chini, M.D., Ph.D., is a Professor at Mayo Clinic with primary and joint appointments in the Department of Anesthesiology and Perioperative Medicine and the Department of Cancer Biology. He is based in Rochester, Minnesota, and leads a research program focused on NAD metabolism, aging, and their roles in diseases such as cancer, obesity, and kidney disease. Education: BS in Biology, Centro Educacional de Niteroi-RJ MD, Universidade do Rio de Janeiro PhD in Biological Chemistry, Universidade do Rio de Janeiro Fellow, Department of Physiology and Biophysics, Mayo Clinic Resident in Anesthesiology, Mayo Clinic College of Medicine Research Interests: Eduardo N. Chini's research investigates the central role of nicotinamide adenine dinucleotide (NAD) in cellular metabolism, aging, and disease. His lab has made foundational discoveries in NAD catabolism, identifying CD38 as the primary enzyme regulating NAD levels in mammals. His work explores SIRT1 regulation via CD38 and DBC1, NAD metabolism in cancer, and its implications in polycystic kidney disease. He is particularly interested in how NAD signaling influences aging, metabolic syndrome, and organ dysfunction. Recent Research Trends: His recent publications (2023–2025) reveal a strong focus on the role of CD38 in aging, immune function, and tissue metabolism. Key themes include NAD+ depletion triggering inflammatory responses, CD38 inhibition as a therapeutic strategy for cardiotoxicity and metabolic aging, and the interplay between senescence, stem cell function, and mitochondrial health. His work increasingly integrates translational models with molecular mechanisms in aging and cancer. Scientific Awards: Florida Investigator of the Year, Mayo Clinic (2024) Glenn/AFAR Breakthroughs in Gerontology Award (2007) Edward C. Kendall Award, Mayo Clinic Alumni Association (2002) Directors Award for Aging Research, Kogod Center on Aging (2018) Distinguished Scientist Seminar Series, Georgetown Medical School (2022) Grants and Leadership: Dr. Chini is a co-Principal Investigator on multiple NIH-funded grants, including projects on CD38 in scleroderma, CLL, and male reproductive aging. He is Co-Director of the Mayo Clinic Mitochondrial Care Center and Associate Director of the Robert and Arlene Kogod Center on Aging. He has served on numerous national review panels and advisory councils, including the NIH Hepatobiliary Pathophysiology Study Section and AFAR's National Scientific Advisory Council. Labs and Teams: Dr. Chini leads a research laboratory at Mayo Clinic focused on NAD metabolism and aging. His team collaborates extensively with experts in cancer biology, mitochondrial medicine, and aging research. He is affiliated with the Mayo Clinic Comprehensive Cancer Center, the Kogod Center on Aging, and the Robert M. and Billie Kelley Pirnie Translational PKD Center.

• Stem Cell Biology
• Cancer Biology
• Molecular Genetics
• +۳ مورد دیگر

Christopher J. Lengner is the Harriet Ellison Woodward Professor and Chair of the Department of Biomedical Sciences at the University of Pennsylvania School of Veterinary Medicine. He is a member of the Institute for Regenerative Medicine, NIH P30 Center for Molecular Studies in Digestive and Liver Diseases, and Abramson Cancer Center, with roles in training and research leadership. Education : PhD in Cell and Molecular Biology from the University of Massachusetts Medical School (2004). His research focuses on molecular mechanisms governing stem cell potency and their dysregulation in diseases like cancer and regenerative failure. Using genetic, genomic, and single-cell approaches in murine and human systems, his lab has uncovered novel pathways in intestinal stem cell hierarchy, cancer ontogeny, and therapeutic targeting. Recent publications highlight work in colorectal cancer metastasis (PI3K/AKT, NOTUM inhibition), intestinal regeneration (mTORC1, FLASH radiotherapy), and tumor microenvironment dynamics. Collaborations span human induced pluripotent cells and patient samples. Scientific Awards : Ruth L. Kirschstein Postdoctoral Fellowship He mentors graduate students (Ryan Cedeno, Maryam Yousefi) and leads the Center for Animal Transgenesis. His lab’s integrative studies bridge basic science to translational applications in oncology and regenerative medicine.

Andrew Godwinمشاهده پروفایل

استاد

• Molecular Oncology
• Precision Medicine
• Biomarker Discovery
• +۳ مورد دیگر

Andrew Godwin is a Professor at the University of Kansas Medical Center , where he serves as the Chancellor’s Distinguished Chair in Biomedical Sciences and Director of Molecular Oncology in the Department of Pathology and Laboratory Medicine. He is also the Deputy Director of the NCI-designated University of Kansas Cancer Center and the Founding Director of the Kansas Institute for Precision Medicine and Biospecimen Shared Resource . Dr. Godwin is a leader in translational research and precision medicine , with a focus on molecular oncology , biomarker discovery , and genomic diagnostics . His work bridges basic and clinical science to improve cancer patient care, particularly in ovarian cancer , Ewing sarcoma , and breast cancer . He has contributed over 230 ovarian cancer-related publications and pioneered studies linking the PI3K/AKT pathway to cancer treatment targets. His research program encompasses liquid biopsies using extracellular vesicles , molecular therapeutics , companion diagnostics , and clinical trial validation . He leads the Biomarker Discovery Laboratory and has secured over $250M in extramural funding , including a $11.4M NIH grant for precision medicine initiatives. His team has developed CELLSEARCH® , the first FDA-cleared test for circulating tumor cells. Notable awards include the Dolph C. Simons, Sr. Higuchi Award (2020), Outstanding Mentorship in Pathology Award (2024), and multiple mentoring accolades from KU. He has mentored over 150 trainees across career stages and leads a multidisciplinary lab with expertise in genomics , proteomics , and bioengineering . Academic Roles: Chancellor’s Distinguished Chair in Biomedical Sciences Director, Molecular Oncology, Pathology and Laboratory Medicine Deputy Director, KU Cancer Center Founding Director, Kansas Institute for Precision Medicine Adjunct Professor, Bioengineering Program, University of Kansas Scientific Awards: KUMC Achievement Award for mentoring postdocs (2014) Chancellor’s Club Award for Research (2018) Dolph C. Simons, Sr. Higuchi Award (2020) KU Excellence in Mentoring Award (2021) Outstanding Mentorship in Pathology (2024) Key Research Themes: Extracellular vesicles as liquid biopsy tools Molecular mechanisms of sarcoma and breast cancer Genomic diagnostics and precision oncology Clinical trial biomarker validation Biospecimen repository leadership

Zhishan Wangمشاهده پروفایل

استاد پژوهشی

• Environmental Carcinogenesis
• Cancer Biology
• Cancer Therapy
• +۴ مورد دیگر

Zhishan Wang, MD, PhD is a Research Professor in the Department of Pathology at Stony Brook University's Renaissance School of Medicine . His work focuses on environmental carcinogenesis , particularly mechanisms of cancer biology and cancer therapy , with a specialization in metal-induced carcinogenicity. Research Interests: Environmental Carcinogenesis Epigenetic and Epitranscriptomic Mechanisms Tumor Microenvironment Remodeling Metal Toxicity Pathobiology Non-Coding RNA Regulatory Networks Scientific Contributions: Analysis of 15 recent publications reveals expertise in: Metal-Induced Oncogenic Pathways (e.g., NF-κB activation, Hedgehog signaling) RNA Modification Dynamics (m6A, lncRNA-splicing interactions) Stem Cell Plasticity in Carcinogenesis Multi-Carcinogen Synergy Mechanisms Epigenetic-Genotoxic Interplay Transcriptomic Reprogramming by Toxicants

Sabine Emingمشاهده پروفایل

استاد

• Tissue regeneration
• Immunometabolism
• Wound healing
• +۵ مورد دیگر

Professor Sabine Eming is a Principal Investigator at the Department of Dermatology & FMNS at the University of Cologne, affiliated with the CMMC and collaborating with CECAD. Her research focuses on the molecular basis of age-related skin pathologies and regenerative responses. Investigates tissue regeneration, immunometabolism, and TOR signaling Develops therapeutic strategies for injured/aging tissues Uses cross-species models (mice, zebrafish, Drosophila, humans) Her work bridges basic science and clinical expertise to translate findings into therapeutic approaches, particularly examining: Metabolic reprogramming in wound healing Immune system's role in regeneration vs. scarring Lipid synthesis and filaggrin processing in skin barrier formation Scarless repair mechanisms in zebrafish vs. mammals She leads research into molecular control systems including: Cell death regulation (FADD-RIPK3 pathways) Nutrient-sensing TOR pathway in skin aging Glutamine metabolism in stem cell maintenance Her group develops genetically modified mouse models and collaborates on clinical trials for impaired healing conditions.

Hokyung Kay Chungمشاهده پروفایل

استادیار

• Synthetic Biology
• Cancer Immunology
• T Cell Engineering
• +۶ مورد دیگر

Hokyung Kay Chung, PhD is an Assistant Professor in the Department of Cell Biology and Physiology at the University of North Carolina at Chapel Hill School of Medicine and a member of the UNC Lineberger Comprehensive Cancer Center. Her research program integrates synthetic biology, immunology, and cancer biology to engineer T cells for enhanced anti-tumor efficacy. Dr. Chung's research focuses on harnessing synthetic biology to reprogram T cell differentiation states for cancer immunotherapy. Her laboratory employs protein engineering, next-generation sequencing, CRISPR screening, and bioinformatics to develop three core platforms: (1) Transcription factor recipes for T cell programming using multiomics atlas-based analysis and in vivo CRISPR screening; (2) Synthetic toolkits for designer immunity including drug-inducible transcription factor circuits and signal rewiring platforms; (3) Hijacking tumors via engineered oncolytic viruses to encode immune modulators. Her work aims to create context-specific cell state programming that enhances T cell therapy efficacy across diverse cancer types. Her publication portfolio demonstrates significant contributions to synthetic immunology, with high-impact papers in Science, Nature Chemical Biology, Cell, and Immunity covering protease-based control systems, T cell differentiation engineering, and tumor microenvironment remodeling. Recent work includes developing sonogenetic CAR-T cells controllable by ultrasound and elucidating metabolic mechanisms of T cell exhaustion. K01 Research Scientist Development Award, NIH, 2023 Keystone Symposia Future of Science Fund Scholarship, 2020 Damon Runyon Fellowship Award, 2019 Salk Women & Science Special Award, 2019 Hans Neurath Outstanding Promise Travel Award, 2017 Dr. Chung leads the Chung Lab at the UNC Lineberger Comprehensive Cancer Center, where she directs research on synthetic T cell engineering. Her lab utilizes advanced techniques including single-cell CRISPR screening, protein engineering, and oncolytic virology to develop next-generation immunotherapies. Current projects focus on creating artificial T cell differentiation pathways and engineering the tumor microenvironment to support persistent anti-tumor immunity.

Vivian Liمشاهده پروفایل

استاد پژوهشی

• Stem Cells
• Tumour Biology
• Developmental Biology
• +۶ مورد دیگر

Vivian Li is a Senior Group Leader and Assistant Research Director at The Francis Crick Institute in London, UK, leading a research group focused on intestinal stem cell biology and colorectal cancer mechanisms. Dr. Li earned her PhD from the University of Hong Kong's Department of Pathology in 2008, researching molecular mechanisms of human colonic development and tumorigenesis, for which she received the Gold Medal Prize. She then completed postdoctoral training with Hans Clevers at the Hubrecht Institute in the Netherlands, funded by the Croucher Foundation Fellowship, focusing on Wnt pathway proteomics and intestinal stem cell genes using transgenic mouse models. Her research program investigates how stem cells maintain healthy gut tissue and what goes wrong during cancer development, with particular emphasis on Wnt signaling pathways. Dr. Li's laboratory utilizes advanced organoid technology ('mini-guts') to study stem cell behavior in three-dimensional cultures, gene editing techniques, and state-of-the-art imaging approaches. Her work spans developmental biology, stem cell research, and cancer biology with significant translational implications. Analysis of her recent publications (2022-2025) reveals a strong focus on cancer stemness mechanisms, intestinal regeneration pathways, Wnt signaling components, and innovative organoid modeling approaches for colorectal cancer. Her research consistently bridges basic science with potential clinical applications in gastrointestinal medicine. Gold Medal Prize for PhD thesis Croucher Foundation Fellowship Dr. Li established her independent laboratory at the MRC National Institute for Medical Research in February 2013 and transitioned to the Francis Crick Institute in 2015. Her research aims to develop tumor-specific therapies for bowel cancer and grow replacement human gut tissue for transplantation or drug testing platforms. She leads a multidisciplinary team utilizing cutting-edge techniques including reverse mouse genetics, ex vivo organoid cultures, and advanced genomic and proteomic analyses to investigate stem cell regulation in health and disease. Her laboratory at the Crick Institute operates within the Biological Research Facility and collaborates extensively with other research groups both within the institute and internationally, contributing significantly to understanding intestinal stem cell niche dynamics and cancer development mechanisms.

Michael Levinمشاهده پروفایل

استاد

• Developmental Biology
• Bioelectricity
• Cognitive Science
• +۷ مورد دیگر

Michael Levin is a Distinguished Professor at Tufts University in the Department of Biology within the School of Arts and Sciences. He serves as Director of both the Allen Discovery Center at Tufts University and the Tufts Center for Regenerative and Developmental Biology. His laboratory investigates the intersection of developmental biology, artificial life, bioengineering, synthetic morphology, and cognitive science. Allen Discovery Center at Tufts Tufts Center for Regenerative and Developmental Biology Tufts/UVM: ICDO Harvard Wyss Institute Stibel Dennett Consortium for Brain and Cognitive Science The Proteus Institute MIT Science and Technology Center EBICS Levin's research focuses on understanding diverse intelligence in evolved, designed, and hybrid complex systems. His lab combines developmental biophysics, computer science, and behavioral science to study how cognition scales up from cellular competencies to organism-level behaviors. A key specialty is developmental bioelectricity—the study of how somatic electrical networks store, process, and act on information to control large-scale body structure. His team creates tools to read and edit the bioelectric code guiding proto-cognitive computations in the body. Levin's publications reveal a strong focus on bioelectricity, morphogenesis, and non-neural cognition across multiple model systems including Xenopus, planarians, and synthetic living constructs. His recent work explores collective intelligence as a unifying concept across biological scales, the development of microfluidic devices for measuring electrical connectivity, and optical estimation of bioelectric patterns in living embryos. His research spans fundamental developmental mechanisms to potential biomedical applications in regeneration and disease treatment. As an editor, Levin serves as Co-Editor-in-Chief of Bioelectricity and Founding Associate Editor of Collective Intelligence. He has mentored numerous post-doctoral fellows and graduate students who have gone on to establish their own research programs. His lab has received significant attention for creating novel biological machines (xenobots) and demonstrating that cells can store and transmit behavioral memory outside the brain. The Levin Lab maintains several significant research initiatives including the Allen Discovery Center at Tufts, the Tufts Center for Regenerative and Developmental Biology, and collaborations with the Wyss Institute at Harvard. The lab employs a multidisciplinary approach combining wet lab experiments with computational modeling to investigate how living systems achieve goal-directed behavior and pattern formation.

• Cancer Metabolism
• Stem Cell Metabolism
• Metabolic Regulation of Cell Growth
• +۵ مورد دیگر

Heather R. Christofk is a Professor in the Department of Biological Chemistry at the David Geffen School of Medicine at UCLA. Her research focuses on the intricate relationship between cellular metabolism and various biological processes, particularly in the contexts of cancer development, stem cell function, and viral infections. Education: PhD in Cell and Developmental Biology from Harvard University (2007) BS in Molecular, Cell, and Developmental Biology from UCLA (2001) Dr. Christofk's research program centers on understanding how metabolic pathways regulate cellular processes in both normal physiology and disease states. Her laboratory has made significant contributions to understanding how cancer cells reprogram their metabolism to support rapid growth and proliferation, with particular focus on glucose metabolism, amino acid utilization, and metabolic adaptations in tumor microenvironments. She has also pioneered work on the metabolic regulation of stem cell function, especially in hair follicle stem cells, demonstrating how metabolic pathways control stem cell activation and differentiation. Her research has important implications for developing novel therapeutic approaches that target cancer metabolism while preserving normal tissue function. Analysis of Dr. Christofk's recent publications reveals a strong focus on metabolic heterogeneity across different biological contexts. Her work spans cancer metabolism (particularly in liposarcoma, melanoma, and hepatocellular carcinoma), stem cell metabolism (especially hair follicle stem cells), viral metabolism (including Epstein-Barr virus and Zika virus), and developmental metabolism (fetal development and organogenesis). A recurring theme is how metabolic pathways serve as regulatory nodes that control cell fate decisions, tumor progression, and therapeutic responses. Selected Research Funding: Metabolic Control of Hair Follicle Stem Cell Homeostasis and Tumorigenesis (NIH R01AR070245, 2018-2023) - Co-Principal Investigator Nutrient regulation of cancer cell growth (NIH R01CA215185, 2017-2022) - Principal Investigator Regulation of the Warburg Effect in Cancer (NIH DP2OD008454, 2011-2016) - Principal Investigator Dr. Christofk's laboratory maintains active collaborations across multiple disciplines, working with clinicians, basic scientists, and computational biologists to address complex questions in metabolism and disease. Her team employs a range of cutting-edge techniques including metabolomics, stable isotope tracing, molecular biology, and in vivo models to investigate metabolic regulation in health and disease.

Shengyu Muمشاهده پروفایل

دانشیار

• Hypertension
• Heart Failure Mechanisms
• Immune-Mediated Pathways in Cardiovascular Disease
• +۴ مورد دیگر

Shengyu Mu is an Associate Professor in the Department of Pharmacology and Toxicology at the University of Arkansas for Medical Sciences (UAMS) College of Medicine. His research focuses on the pathogenesis of hypertension and its progression to heart failure, with a particular emphasis on immune mechanisms in renal salt retention. Mu holds an M.D. from TianJin Medical University (2004) and a Ph.D. from the University of Tokyo (2011). His research portfolio includes NIH-funded projects investigating T cell homing to the kidney and immune memory in hypertension. Current grants span NIH-NHLBI (2R01 HL146713), American Heart Association (AHA23TPA1076467), and USDA-NIFA collaborations. Completed projects include studies on renal lymph-angiogenesis and macrophage metabolism in diabetes/tuberculosis comorbidity. Research areas integrate physiology, molecular genetics, and epigenetics to bridge basic science and clinical applications. The Mu Lab includes Assistant Professor Yunmeng Liu, Ph.D. candidates Christoph Mora and Kathrine Deck, and research team members recognized for awards like the AHA Predoctoral Fellowship and APS Research Recognition Awards. Key themes include CD8+ T cell activation, IFNγ signaling, and macrophage transition in hypertension pathogenesis.

Jerry W. Shayمشاهده پروفایل

استاد

• Aging Research
• Cancer Biology
• Telomere Biology
• +۳ مورد دیگر

Jerry W. Shay is a Professor in the Department of Cell Biology at UT Southwestern Medical Center, holding the Southland Financial Corporation Distinguished Chair in Geriatric Research. He also serves as Associate Director for Education and Training at the Harold Simmons Comprehensive Cancer Center. His research focuses on telomere biology, aging, and cancer therapy development, with an emphasis on targeting telomerase in cancer treatment and understanding age-related disease mechanisms. Shay earned his BA in Zoology/Cell Biology from the University of Texas at Austin (1966), MA in Cell Biology from the University of Kansas (1968), and PhD in Developmental Biology from the University of Colorado Boulder (1975). He joined UT Southwestern in 1975, advancing from Assistant/Associate Professor to full Professor in 1993. His research interests include telomere dysfunction-induced anti-tumor immunity, cancer therapy resistance, and the role of telomerase in cellular aging. Key projects involve developing therapies like 6-thio-dG, which targets telomerase-dependent cancers, and studying the interplay between environmental toxins and colorectal carcinogenesis. Awarded numerous honors including the UT Regent’s Outstanding Teaching Award (2012) and the Piper Professorship (2013), Shay has contributed to over 30 patents, including methods to detect telomerase activity and compounds targeting cancer cell adhesion. His lab collaborates with companies like Maia Biotechnology and Reata Pharmaceuticals to translate research into clinical applications. Shay’s work bridges basic science and translational research, with ongoing projects in radiation-induced cancer progression, immune modulation in cancer treatment, and telomere measurement technologies like the TeSLA assay.

Luke Lairsonمشاهده پروفایل

استاد

• Chemical Biology
• Drug Discovery
• Cancer Biology
• +۴ مورد دیگر

Professor Luke Lairson leads the Lairson Laboratory at The Scripps Research Institute (TSRI), focusing on chemical biology to study cell fate mechanisms in disease. His work spans small molecule discovery targeting cancer stem cells, tumor microenvironment modulation, and myelination enhancement using primary human and rodent cell models. Education: PhD in Chemistry (2007, University of British Columbia), BS in Biochemistry (2002, University of Guelph). Professional roles include Assistant Professor at TSRI (2010–present), Principal Investigator at the Genomics Institute of the Novartis Research Foundation (2010–2011), and Director of High Throughput Discovery at California Institute for Biomedical Research (2016–2017). Research Interests: Chemical approaches to cancer immunotherapy, drug discovery for neurodegenerative diseases, and modulation of immune checkpoint proteins. Key projects include STING agonist development, HSP90 inhibitors, and metabolite-driven oligodendrocyte maturation. Publications: Over 50 peer-reviewed articles, including high-impact work in PNAS , Nature Chemical Biology , and Cancer Research . Recent focus areas include microbiota-derived STING activators and JAK-inhibitor immunotherapy combinations. Awards: Canadian Society for Chemistry Boehringer Ingelheim Thesis Award (2010), Royal Society Short Visit Award (2007), and multiple scholarships for organic chemistry innovation. Lab Activities: Integrates high-content screening, medicinal chemistry, and proteomics to identify mechanism-based therapies. Current initiatives include repurposing drugs for remyelination and developing non-nucleotide STING agonists for systemic cancer immunotherapy.

Jingsong Zhouمشاهده پروفایل

استاد

• Neuromuscular Diseases
• Striated Muscle Physiology
• Calcium Signaling
• +۴ مورد دیگر

Dr. Jingsong Zhou is a Professor of Kinesiology and Associate Director of the Bone-Muscle Research Center at The University of Texas at Arlington. Her research focuses on neuromuscular diseases, particularly Amyotrophic Lateral Sclerosis (ALS), with expertise in striated muscle physiology, calcium signaling, and mitochondrial dysfunction. She leads the Neuromuscular Diseases Lab, which develops genetic mouse models and molecular probes to study ALS mechanisms. Dr. Zhou’s work has been supported by NIH, MDA, DOD, and the ALS Association. She serves on the NIH SMEP study section and has over 20 years of academic experience, including postdoctoral training at Vanderbilt University College of Medicine and a PhD from Rush University School of Medicine. Education: Postdoctoral Fellow in Pharmacology, Vanderbilt University College of Medicine (2001) PhD in Molecular Biophysics and Physiology, Rush University School of Medicine (1997) Diploma in Medicine, Hunan Medical University (Xiangya Medical School) (1986) Research Interests: Mechanisms of calcium signaling and mitochondrial dysfunction in ALS Role of sarcolemma repair and autophagy in neuromuscular disease progression Development of therapeutic strategies targeting mitochondrial health and membrane integrity Grants and Funding: NIH grants focused on ALS pathogenesis and muscle-bone interactions Support from MDA, DOD, and ALS Association for translational research projects Labs and Teams: Director of the Neuromuscular Diseases Lab at UT Arlington Collaborations in developing mouse models and molecular tools for ALS research

Maxim V. Berezovskiمشاهده پروفایل

استاد

• Analytical Chemistry
• Bioanalytical Chemistry
• Aptamers (Therapeutics and Diagnostics)
• +۴ مورد دیگر

Maxim V. Berezovski is a Full Professor in the Department of Chemistry and Biomolecular Sciences at the University of Ottawa , Faculty of Science. His research focuses on bioanalytical chemistry , aptamer development , and biomarker discovery , particularly in cancer and immune cell biology. His lab specializes in Kinetic Capillary Electrophoresis (KCE) , aptamer-based biosensors, and single-cell analysis. Research interests include: Therapeutic and diagnostic applications of nucleic acid and peptide aptamers Biomarker identification for cancers (e.g., breast, glial tumors) Proteomic/metabolomic analyses of exosomes and extracellular vesicles Recent work emphasizes aptamer-driven innovations, such as: Fluorescence-guided brain tumor surgery Quantitative detection of SARS-CoV-2 proteins Molecular imaging of tumors using infrared-labeled aptamers Publications span aptamer engineering , cancer diagnostics , and environmental impacts on proteomics . Collaborations focus on interdisciplinary applications in medicine, biotechnology, and environmental science.

• Metabolomics
• Analytical Chemistry
• Plant-Microbe Interaction
• +۲ مورد دیگر

Rainer Schuhmacher is a Full Professor for Plant and Microbe Metabolomics at the University of Natural Resources and Life Sciences, Vienna (BOKU), affiliated with the Department of Agricultural Sciences and the Institute of Bioanalytics and Agro-Metabolomics in Tulln an der Donau. His research focuses on metabolomics, analytical chemistry, and plant-microbe interactions, with emphasis on fungal secondary metabolites, mycotoxin resistance, and environmental stress responses in crops. He leads projects funded by the Austrian Science Fund (FWF), European Commission, and national agencies. Research interests span: Metabolomic profiling of plant-pathogen interactions (e.g., Fusarium -wheat systems) Stable isotope-assisted techniques for metabolic pathway analysis Cold stress mitigation in plants using Antarctic bacteria Development of computational tools for untargeted metabolomics data processing His work integrates analytical chemistry, bioinformatics, and molecular biology to study metabolic crosstalk in agricultural systems. Awards include the Fritz-Feigl-Preis (2012) and Dr.-Wolfgang-Houska-Preis (2005). He has supervised multiple PhD projects and leads the Plant-Microbe Metabolomics group, managing core metabolomics platforms and international collaborations. Key projects: Chemical crosstalk in mycoparasitic interactions (FWF) Metabolomics of cold stress tolerance mediated by psychrotolerant bacteria Extension of metabolomics platforms for plant-pathogen studies